Earnings History Data for Jazz Pharmaceuticals plc (JAZZ) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Jazz Pharmaceuticals plc

Jazz Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on identifying, developing and commercializing innovative products to meet unmet medical needs in neurology and psychiatry. Company's goal is to build a broad portfolio of products through a combination of internal development and acquisition/in-licensing activities and to utilize our specialty sales force to promote products in our target markets. They apply novel formulations and drug delivery technologies to known drug compounds, and compounds with the same mechanism of action or similar chemical structure as marketed products, to improve patient care by improving efficacy, reducing adverse side effects or increasing patient compliance relative to existing therapies. Based in Palo Alto, California, the company is committed to working closely with patients, patient advocacy groups and healthcare professionals.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
06-11-2024	AH		JAZZ	Jazz Pharmaceuticals plc	6,760	5.86	4.54	4.22	Jazz Pharmaceuticals Non-GAAP EPS of $6.61 beats by $1.11, revenue of $1.05B beats by $10M [11/6/2024 4:40 PM]	118.84	7.29 (6.54%)	117.00	5.45 (4.89%)	99.06 - 134.48	1,300,629	500,000	1,591
Jazz Pharmaceuticals Non-GAAP EPS of $6.61 beats by $1.11, revenue of $1.05B beats by $10M [11/6/2024 4:40 PM] Jazz Pharmaceuticals Announces Third Quarter 2024 Financial Results [2024-11-06 04:05PM]
31-07-2024	AH		JAZZ	Jazz Pharmaceuticals plc	7,000	4.67	3.80	3.83	Jazz Pharmaceuticals beats Q2 estimates, narrows FY revenue guidance [7/31/2024 4:10 PM]	114.33	4.08 (3.70%)	111.00	0.75 (0.68%)	99.06 - 146.70	2,032,526	570,000	2,619
Jazz Pharmaceuticals beats Q2 estimates, narrows FY revenue guidance [7/31/2024 4:10 PM]
01-05-2024	AH		JAZZ	Jazz Pharmaceuticals plc	6,930	1.98	3.53	3.20	Jazz Pharmaceuticals misses top-line and bottom-line estimates; reaffirms FY24 outlook [5/1/2024 4:23 PM]	109.35	-0.96 (-0.87%)	106.50	-3.81 (-3.45%)	103.01 - 146.70	964,268	570,000	1,153
Jazz Pharmaceuticals misses top-line and bottom-line estimates; reaffirms FY24 outlook [5/1/2024 4:23 PM]
28-02-2024	AH		JAZZ	Jazz Pharmaceuticals	8,328	4.40	5.26	0.00	Jazz Pharmaceuticals Non-GAAP EPS of $5.02 misses by $0.16, revenue of $1.01B in-line [2/28/2024 4:18 PM]	119.01	-10.69 (-8.24%)	127.80	-1.90 (-1.46%)	111.25 - 147.98	1,922,172	500,000	788
Jazz Pharmaceuticals Non-GAAP EPS of $5.02 misses by $0.16, revenue of $1.01B in-line [2/28/2024 4:18 PM]
08-11-2023	AH		JAZZ	Jazz Pharmaceuticals plc	8,380	4.22	4.21	4.53	Jazz Pharmaceuticals Non-GAAP EPS of $4.84 misses by $0.09, revenue of $972.14M beats by $2.8M [11/8/2023 4:12 PM]	116.57	-11.67 (-9.10%)	128.51	0.27 (0.21%)	116.32 - 160.96	1,544,163	620,000	42,052
Jazz Pharmaceuticals Non-GAAP EPS of $4.84 misses by $0.09, revenue of $972.14M beats by $2.8M [11/8/2023 4:12 PM]
09-08-2023	AH		JAZZ	Jazz Pharmaceuticals plc	8,420	3.83	3.68	3.62	Jazz Pharmaceuticals Non-GAAP EPS of $4.51 beats by $0.08, revenue of $957.32M beats by $15.16M [8/9/2023 4:09 PM]	135.19	2.19 (1.65%)	137.00	4.00 (3.01%)	120.64 - 163.31	864,540	390,000	929
Jazz Pharmaceuticals Non-GAAP EPS of $4.51 beats by $0.08, revenue of $957.32M beats by $15.16M [8/9/2023 4:09 PM]
10-05-2023	AH	4:05 PM ET (May 10)	JAZZ	Jazz Pharmaceuticals plc	8,780	3.20	3.58	3.13	Jazz Pharmaceuticals Non-GAAP EPS of $3.95 misses by $0.27, revenue of $892.8M misses by $5.25M [5/10/2023 4:12 PM]	137.06	0.53 (0.39%)	137.50	0.97 (0.71%)	125.36 - 163.31	834,225	490,000	30,910
Jazz Pharmaceuticals Non-GAAP EPS of $3.95 misses by $0.27, revenue of $892.8M misses by $5.25M [5/10/2023 4:12 PM] Jazz Pharmaceuticals reaffirms 2023 guidance [5/10/2023 6:40 PM]
01-03-2023	AH	4:05 PM ET (Mar 1)	JAZZ	Jazz Pharmaceuticals plc	9,160	-0.84	-0.20	3.66	Jazz Pharmaceuticals Non-GAAP EPS of -$0.07 misses by $1.19, revenue of $972.12M misses by $3.75M, guidance in-line [3/1/2023 4:10 PM]	144.56	4.05 (2.88%)	145.00	4.49 (3.20%)	125.36 - 169.98	1,135,345	640,000	3,674
Jazz Pharmaceuticals Non-GAAP EPS of -$0.07 misses by $1.19, revenue of $972.12M misses by $3.75M, guidance in-line [3/1/2023 4:10 PM] Jazz Pharma Q4 2022 results are a miss, but 2023 outlook hits a high note; stock up 5% [3/1/2023 5:12 PM] Senators introduce legislation to eliminate drug company loophole that delays competition [3/2/2023 10:54 AM]
09-11-2022	AH	4:05 PM ET (Nov 9)	JAZZ	Jazz Pharmaceuticals plc	9,110	4.53	4.35	3.64	Jazz Pharmaceuticals Non-GAAP EPS of $5.17 beats by $0.50, revenue of $940.65M in-line [11/9/2022 4:15 PM]	149.91	9.91 (7.08%)	140.00	0.0 (0.00%)	117.64 - 169.98	925,557	520,000	79,961
Jazz Pharmaceuticals Non-GAAP EPS of $5.17 beats by $0.50, revenue of $940.65M in-line [11/9/2022 4:15 PM] Jazz Pharmaceuticals 2022 adjusted EPS guidance range includes consensus estimate [11/9/2022 5:11 PM] Jazz Pharmaceuticals Announces Third Quarter 2022 Financial Results and Raises Total Revenue Guidance Mid-point [Nov-09-22 04:05PM] Why Jazz Pharmaceuticals (JAZZ) Might Surprise This Earnings Season [Nov-08-22 08:32AM]
03-08-2022	AH	4:10 PM ET (Aug 3)	JAZZ	Jazz Pharmaceuticals plc	9,840	3.62	3.63	3.29	Jazz Pharmaceuticals Non-GAAP EPS of $4.30 beats by $0.11, revenue of $932.88M beats by $30.37M [8/3/2022 4:19 PM]	150.87	-0.79 (-0.52%)	3.92	-0.40 (-9.26%)	117.64 - 169.98	774,436	480,000	51,552
Jazz Pharmaceuticals Non-GAAP EPS of $4.30 beats by $0.11, revenue of $932.88M beats by $30.37M [8/3/2022 4:19 PM] 2 Growth Stocks That Are Unapologetically Crushing the Bear Market [Aug-02-22 10:15AM] Is Immunocore (IMCR) Outperforming Other Medical Stocks This Year? [Aug-02-22 09:40AM] Moderna (MRNA) Beats on Q2 Earnings, Starts $3B Buyback Program [Aug-03-22 12:47PM] Sarepta (SRPT) Q2 Earnings Miss, DMD Drugs' Sales Robust [Aug-03-22 12:44PM] Esperion (ESPR) Q2 Earnings and Revenues Miss Estimates [Aug-03-22 11:43AM]
04-05-2022	AH	4:05 PM ET (May 4)	JAZZ	Jazz Pharmaceuticals	9,892	3.13	3.75	0.00	Jazz Pharmaceuticals Non-GAAP EPS of $3.73 misses by $0.16, revenue of $813.72M misses by $40.01M; raises FY22 guidance [5/4/2022 4:17 PM]	152.97	-4.46 (-2.83%)	157.43	0.0 (0.00%)	117.64 - 189.00	976,851	550,000	7,296
Jazz Pharmaceuticals Non-GAAP EPS of $3.73 misses by $0.16, revenue of $813.72M misses by $40.01M; raises FY22 guidance [5/4/2022 4:17 PM] Jazz, Sumitomo on Wednesday inked licensing deal for a sleep disorders treatment candidate [5/5/2022 2:32 PM] Jazz Pharmaceuticals to Participate in the BofA Securities 2022 Global Healthcare Conference [May-03-22 04:15PM] Jazz Pharmaceuticals Announces First Quarter 2022 Financial Results and Raises 2022 Financial Guidance [May-04-22 04:10PM] Jazz Pharmaceuticals and Sumitomo Pharma Announce Exclusive License Agreement to Develop and Commercialize DSP-0187, a Potent, Highly Selective Oral Orexin-2 Receptor Agonist [May-04-22 04:05PM] Jazz Pharmaceuticals (JAZZ) Lags Q1 Earnings and Revenue Estimates [May-04-22 06:05PM] JAZZ Q1 Earnings Miss, Sales Robust, 2022 Guidance Raised [May-05-22 10:32AM] Jazz Pharma, Sumitomo Pharma Ink Licensing Pact For Sleeping Disorder Candidate [May-05-22 12:04PM]
01-03-2022	AH	4:05 PM ET (Mar 1)	JAZZ	Jazz Pharmaceuticals plc	8,560	3.66	2.96	3.56	Jazz Pharmaceuticals Non-GAAP EPS of $4.21 beats by $0.58, revenue of $896.73M beats by $30.02M [3/1/2022 4:17 PM]	153.03	16.40 (12.00%)	139.11	2.48 (1.82%)	117.64 - 189.00	1,788,413	620,000	215
Jazz Pharmaceuticals Non-GAAP EPS of $4.21 beats by $0.58, revenue of $896.73M beats by $30.02M [3/1/2022 4:17 PM] Jazz Pharma nears a six-month high as analysts cheer Q4 results [3/2/2022 11:27 AM] Jazz Pharmaceuticals to Participate in Upcoming March Investor Conferences [Feb-28-22 04:15PM] ImmunoGen (IMGN) Q4 Earnings and Sales Outpace Estimates [Feb-28-22 10:20AM] JAZZ PHARMACEUTICALS ANNOUNCES FULL YEAR AND FOURTH QUARTER 2021 FINANCIAL RESULTS [Mar-01-22 04:05PM] Jazz Pharmaceuticals (JAZZ) Tops Q4 Earnings and Revenue Estimates [Mar-01-22 05:45PM] JAZZ Q4 Earnings Top, Sales Ride on New & Acquired Drugs [Mar-02-22 09:40AM] Why Jazz Pharmaceuticals Stock Is Racing Higher Today [Mar-02-22 02:20PM]
09-11-2021	AH	4:05 PM ET (Nov 9)	JAZZ	Jazz Pharmaceuticals plc	8,190	3.64	2.60	3.86	Jazz Pharmaceuticals EPS beats by $0.89, beats on revenue [11/9/2021 4:15 PM]	136.24	4.25 (3.22%)	135.00	3.00 (2.27%)	126.01 - 189.00	814,617	490,000	5,011
Jazz Pharmaceuticals EPS beats by $0.89, beats on revenue [11/9/2021 4:15 PM] Jazz Pharma rises after-hours on quarterly earning beat, full-year guidance raise [11/9/2021 5:30 PM] Jazz Pharmaceuticals Announces Third Quarter 2021 Financial Results And Raises Full Year Earnings Guidance [Nov-09-21 04:05PM] Jazz Pharmaceuticals to Participate in Upcoming November Investor Conferences [Nov-09-21 04:15PM] Jazz Pharmaceuticals (JAZZ) Tops Q3 Earnings and Revenue Estimates [Nov-09-21 07:15PM] Jazz Pharmaceuticals PLC (JAZZ) Q3 2021 Earnings Call Transcript [Nov-10-21 12:31AM] Jazz Pharma (JAZZ) Q3 Earnings Beat, New Drugs Drive Sales [Nov-10-21 09:02AM]
03-08-2021	AH	4:05 PM ET (Aug 3)	JAZZ	Jazz Pharmaceuticals plc	10,290	3.29	2.91	3.26	Jazz Pharmaceuticals EPS beats by $0.45, beats on revenue [8/3/2021 4:10 PM]	153.51	-17.99 (-10.49%)	172.50	1.00 (0.58%)	109.53 - 189.00	2,392,745	460,000	13,371
Jazz Pharmaceuticals EPS beats by $0.45, beats on revenue [8/3/2021 4:10 PM] Jazz Pharmaceuticals posts Q2 earnings beat, reaffirms FY forecast [8/3/2021 4:31 PM] 10 Best CBD Stocks to Invest In [Aug-02-21 01:31PM] How Investors Can Grab Better Returns for Medical Using the Zacks ESP Screener [Aug-03-21 08:50AM] Jazz Pharmaceuticals Announces Second Quarter 2021 Financial Results [Aug-03-21 04:05PM] Jazz Pharmaceuticals (JAZZ) Tops Q2 Earnings and Revenue Estimates [Aug-03-21 07:05PM] Jazz Pharmaceuticals PLC (JAZZ) Q2 2021 Earnings Call Transcript [Aug-03-21 11:01PM] Jazz Pharma (JAZZ) Q2 Earnings Beat, Sales Ride on GW Buyout [Aug-04-21 10:35AM]
04-05-2021	AH	4:05 PM ET (May 4)	JAZZ	Jazz Pharmaceuticals plc	9,430	3.42	3.09	-0.05	Jazz Pharmaceuticals EPS beats by $0.19, misses on revenue; affirms FY2021 guidance [5/4/2021 4:10 PM]	170.79	10.59 (6.61%)	161.00	0.80 (0.50%)	101.81 - 178.64	1,323,917	650,000	1,883
Jazz Pharmaceuticals EPS beats by $0.19, misses on revenue; affirms FY2021 guidance [5/4/2021 4:10 PM] Jazz closes acquisition of GW Pharmaceuticals [5/5/2021 9:29 AM] Jazz Pharmaceuticals Plc to Host Earnings Call [May-04-21 02:30PM] Jazz Pharmaceuticals Announces First Quarter 2021 Financial Results [May-04-21 04:05PM] Jazz Pharmaceuticals to Participate in Three Investor Conferences in May 2021 [May-04-21 04:15PM] Jazz Pharma Easily Beats Earnings Views, But Sales Come In Light [May-04-21 04:14PM] Jazz Expects To Buy GW Pharma This Month And Eyes Breakout [May-04-21 05:00PM] Jazz Pharmaceuticals (JAZZ) Beats Q1 Earnings and Revenue Estimates [May-04-21 07:20PM] Jazz Pharmaceuticals PLC (JAZZ) Q1 2021 Earnings Call Transcript [May-04-21 08:30PM] Jazz Pharmaceuticals Completes Acquisition of GW Pharmaceuticals plc [May-05-21 09:15AM] Jazz Pharma (JAZZ) Q1 Earnings Beat, Sales Miss, Stock Down [May-05-21 09:25AM] Jazz Pharmaceuticals' Acquisition of GW Pharmaceuticals Closes [May-05-21 04:54PM]
23-02-2021	AH	4:05 PM ET (Feb 23)	JAZZ	Jazz Pharmaceuticals plc	8,950	3.56	3.58	4.04	Jazz Pharmaceuticals EPS misses by $0.20, beats on revenue [2/23/2021 4:08 PM]	173.46	15.99 (10.15%)	157.47	0.0 (0.00%)	86.88 - 178.64	1,911,299	754,299	8,800
Jazz Pharmaceuticals EPS misses by $0.20, beats on revenue [2/23/2021 4:08 PM] Jazz sees product revenues rise 14% in Q4 but adjusted net income falls nearly 10% [2/23/2021 4:56 PM] Why Wall Street Wasn't Bothered by Jazz Pharmaceuticals' Mixed Q4 Results [Feb-24-21 06:00AM] Recap: Jazz Pharmaceuticals Q4 Earnings [Feb-23-21 04:24PM] Jazz Pharmaceuticals Plc to Host Earnings Call [Feb-23-21 02:30PM]
02-11-2020	AH	4:05 PM ET (Nov 2)	JAZZ	Jazz Pharmaceuticals plc	8,080	3.86	3.53	3.65	Jazz Pharmaceuticals EPS beats by $0.23, beats on revenue [11/2/2020 4:12 PM]	148.53	1.28 (0.87%)	154.25	7.00 (4.75%)	86.88 - 156.26	1,029,023	450,572	15,082

04-08-2020	AH	4:05 PM ET (Aug 4)	JAZZ	Jazz Pharmaceuticals plc	5,990	3.26	2.96	3.65	Jazz Pharmaceuticals EPS beats by $0.60, beats on revenue [8/4/2020 4:09 PM]	122.24	11.76 (10.64%)	113.00	2.52 (2.28%)	86.88 - 154.24	621,222	586,509	5,697

05-05-2020	AH	4:05 PM ET (May 5)	JAZZ	Jazz Pharmaceuticals plc	6,070	-0.05	0.21	3.27	Jazz Pharmaceuticals EPS misses by $0.38, misses on revenue [5/5/2020 4:15 PM]	110.41	1.68 (1.55%)	0.0	0.0 (0.00%)	86.88 - 154.24	514,702	492,471	0